H. Lundbeck, Cipralex® approved for the treatment of generalised anxiety disorder in the EU


                        
The European health authorities today approved Cipralex® for the treatment of generalised anxiety disorder (GAD). The approval is based on seven clinical studies involving more than 1,600 patients. The studies all demonstrate that Cipralex® is an effective and well-tolerated drug for the treatment of GAD.

Subscribe

Documents & Links